Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bitran

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 1, 1989
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy aloneD E Hallahan, R Farah, E E Vokes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphomaJacob D Bitran, Leonard Klein, Doreen Link, et al.
Cancer|January 1, 1986
Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary reportJ D Bitran, H M Golomb, P C Hoffman, et al.
Cancer|February 15, 1981
Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstructionJ B Miller, D Variakojis, J D Bitran, et al.
Cancer|January 15, 1989
High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancerS F Williams, J D Bitran, P C Hoffman, et al.
Cancer|November 15, 1985
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patientsK V Shepard, H M Golomb, J D Bitran, et al.
Cancer|August 1, 1990
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancerE E Vokes, S Vijayakumar, P C Hoffman, et al.
Cancer|November 15, 1986
A 10-year experience with combined modality therapy for stage III small cell lung carcinomaR H Jacobs, A Greenburg, J D Bitran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancerS F Williams, J D Bitran, L Kaminer, et al.
Journal of Oncology Practice|October 2, 2019
Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement StrategyJon M Richards, Trever B Burgon, Diana Tamondong-Lachica, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|October 1, 1989
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy aloneD E Hallahan, R Farah, E E Vokes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphomaJacob D Bitran, Leonard Klein, Doreen Link, et al.
Cancer|January 1, 1986
Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary reportJ D Bitran, H M Golomb, P C Hoffman, et al.
Cancer|February 15, 1981
Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstructionJ B Miller, D Variakojis, J D Bitran, et al.
Cancer|January 15, 1989
High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancerS F Williams, J D Bitran, P C Hoffman, et al.
Cancer|November 15, 1985
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patientsK V Shepard, H M Golomb, J D Bitran, et al.
Cancer|August 1, 1990
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancerE E Vokes, S Vijayakumar, P C Hoffman, et al.
Cancer|November 15, 1986
A 10-year experience with combined modality therapy for stage III small cell lung carcinomaR H Jacobs, A Greenburg, J D Bitran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancerS F Williams, J D Bitran, L Kaminer, et al.
Journal of Oncology Practice|October 2, 2019
Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement StrategyJon M Richards, Trever B Burgon, Diana Tamondong-Lachica, et al.
Pageof 20